SCHEMBL117475

SCHEMBL117475

CCOC(=O)Cc1ccc(S(=O)(=O)NCc2ccccc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.67
CYP2D6 P10635 1/20 0.67
CYP2C9 P11712 1/20 0.67
CYP2C19 P33261 1/20 0.67
CA12 O43570 2/20 0.61
CA9 Q16790 2/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
ATM Q13315 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
ALDH1A1 P00352 5/20 0.57
KEAP1 Q14145 1/20 0.56
LMNA P02545 4/20 0.55
PRMT1 Q99873 1/20 0.55
KDM4E B2RXH2 1/20 0.55
HSD17B10 Q99714 1/20 0.55
GAA P10253 1/20 0.55
MAPT P10636 1/20 0.55
HPGD P15428 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10463317 0.88 MAPT (0.63) TSHRCYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL11113546 0.84 KEAP1 (0.52) TSHRCYP2D6CYP2C9CYP2C19CA12
SCHEMBL20981392 0.83 KEAP1 (0.63) TSHRCYP2D6CYP2C9CYP2C19CA12
SCHEMBL11107041 0.83 TBXA2R (0.58) ALDH1A1LMNAMAPTSMN1; SMN2CA1
SCHEMBL5458079 0.82 KEAP1 (0.69) TSHRCYP2D6CYP2C9CYP2C19CA12
SCHEMBL11363199 0.81 TSHR (0.75) TSHRCYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL10567274 0.80 KMT2A (0.55) TSHRCYP2D6CYP2C9CYP2C19ALDH1A1
SCHEMBL2517599 0.80 LMNA (0.62) TSHRALDH1A1LMNAKDM4EHSD17B10
SCHEMBL11455802 0.80 ALDH1A1 (0.73) TSHRCYP2C9CYP2C19ALDH1A1LMNA
SCHEMBL2519148 0.80 ALDH1A1 (0.58) TSHRCYP2C9CYP2C19CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2012-04-19 US disclosed
EP-2424517-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RaQualia Pharma Inc (JP) 2012-03-07 EP disclosed
WO-2010125831-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS TRPM8, TRPM5, TRPM6 TSHR 1240/4885CYP2D6 1316/4885CYP2C9 1354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.